サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1790430

米国のDNA合成の市場規模、シェア、動向分析レポート：サービスタイプ別、用途別、最終用途別、セグメント別予測、2025年～2033年

U.S. DNA Synthesis Market Size, Share & Trends Analysis Report By Service Type (Gene Synthesis, Oligonucleotide Synthesis), By Application (Research Development, Diagnostics), By End Use, And Segment Forecasts, 2025 - 2033

出版日
ページ情報
英文 100 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.16円
米国のDNA合成の市場規模、シェア、動向分析レポート：サービスタイプ別、用途別、最終用途別、セグメント別予測、2025年～2033年
出版日: 2025年07月29日
発行: Grand View Research
ページ情報: 英文 100 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

米国のDNA合成市場のサマリー

米国のDNA合成の市場規模は2024年に12億5,000万米ドルと推計され、2033年には46億2,000万米ドルに達すると予測され、2025年から2033年までのCAGRは15.93%で拡大します。この高成長の背景には、合成生物学、個別化医療、バイオテクノロジー研究における需要の増加があります。遺伝子編集技術の進歩と米国のDNA合成コストの低下が市場拡大をさらに加速させています。米国は、研究開発への旺盛な投資と確立されたバイオテクノロジーインフラに支えられ、世界のゲノム技術革新における重要なプレーヤーであり続けています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 米国のDNA合成市場の変数、動向、範囲

  • 市場系統の見通し
    • 親市場の見通し
    • 関連/補助的な市場見通し。
  • 市場力学
    • 市場促進要因分析
    • 市場抑制要因分析
  • 米国のDNA合成市場分析ツール
    • 業界分析- ポーターのファイブフォース分析
    • PESTEL分析

第4章 米国のDNA合成市場：サービスタイプ別の推定・動向分析

  • セグメントダッシュボード
  • 米国のDNA合成市場の変動分析：サービスタイプ別
  • 米国のDNA合成市場の規模と動向分析：サービスタイプ別、2021年～2033年
  • オリゴヌクレオチド合成
    • タイプ別
    • 長さ別
  • 遺伝子合成
    • タイプ別
    • 長さ別

第5章 米国のDNA合成市場：用途別の推定・動向分析

  • セグメントダッシュボード
  • 米国のDNA合成市場の変動分析：用途別
  • 米国のDNA合成市場の規模と動向分析：用途別、2021年～2033年
  • 研究開発
    • オリゴヌクレオチド合成
    • 遺伝子合成
  • 診断
  • 治療薬
    • RNAi療法
    • アンチセンスおよびオリゴヌクレオチドベースの治療法
    • その他

第6章 米国のDNA合成市場：最終用途別の推定・動向分析

  • セグメントダッシュボード
  • 米国のDNA合成市場の変動分析：最終用途別
  • 米国のDNA合成市場の規模と動向分析：最終用途別、2021年～2033年
  • バイオ医薬品・診断薬企業
  • 学術調査機関
  • 受託研究機関

第7章 競合情勢

  • 企業/競合の分類
  • 戦略マッピング
  • 企業市況分析、2024年
  • 企業プロファイル/上場企業
    • Thermo Fisher Scientific Inc.
    • Twist Bioscience
    • BIONEER CORPORATION
    • Eton Bioscience, Inc
    • LGC Biosearch Technologies
    • IBA Lifesciences GmbH
    • Eurofins Scientific
    • Integrated DNA Technologies, Inc.
    • Quintara Biosciences
    • GenScript
図表

List of Tables

  • Table 1 List of abbreviation
  • Table 2 U.S. DNA synthesis market, by service type, 2021 - 2033 (USD Million)
  • Table 3 U.S. DNA synthesis market, by application, 2021 - 2033 (USD Million)
  • Table 4 U.S. DNA synthesis market, by end use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 U.S. DNA synthesis market segmentation
  • Fig. 2 Data analysis models
  • Fig. 3 Market formulation and validation
  • Fig. 4 Data validating & publishing
  • Fig. 5 Market research process
  • Fig. 6 Information procurement
  • Fig. 7 Primary research
  • Fig. 8 Value-chain-based sizing & forecasting
  • Fig. 9 QFD modelling for market share assessment
  • Fig. 10 Market formulation & validation
  • Fig. 11 Commodity flow analysis
  • Fig. 12 Market outlook
  • Fig. 13 Segments snapshot
  • Fig. 14 Competitive landscape snapshot
  • Fig. 15 U.S. DNA synthesis market value, 2024 (USD billion)
  • Fig. 16 Market trends & outlook
  • Fig. 17 PESTEL analysis
  • Fig. 18 Porter's five forces analysis
  • Fig. 19 U.S. DNA synthesis market: Service type outlook & key takeaways
  • Fig. 20 U.S. DNA synthesis market: Service type movement analysis
  • Fig. 21 Oligonucleotide synthesis market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 22 Standard oligonucleotide synthesis market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 23 Custom oligonucleotide synthesis market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 24 Less than 50 nt market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 25 51-100 nt market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 26 101-150 nt market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 27 More than 150 nt market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 28 Gene synthesis market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 29 Custom gene synthesis market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 30 Gene library synthesis market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 31 Less than 500 nt market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 32 501-1,000 nt market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 33 501-1,000 nt market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 34 1,501-2,000 nt market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 35 2,001-2,500 nt market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 36 More than 2,500 nt market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 37 U.S. DNA synthesis Market: Application outlook & key takeaways
  • Fig. 38 U.S. DNA synthesis Market: Application movement analysis
  • Fig. 39 Research and development market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 40 Oligonucleotide synthesis market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 41 PCR market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 42 NGS market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 43 CRISPR market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 44 Cloning and mutagenesis market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 45 Others market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 46 Gene synthesis market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 47 Synthetic biology market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 48 Vaccine development market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 49 Genetic engineering market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 50 Others market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 51 Diagnostics market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 52 Therapeutics market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 53 RNAi therapies market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 54 Antisense oligonucleotide-based therapies market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 55 Others market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 56 U.S. DNA synthesis market: End Use outlook & key takeaways
  • Fig. 57 U.S. DNA synthesis market: End Use movement analysis
  • Fig. 58 Biopharmaceutical and diagnostics companies market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 59 Academic & research institutes market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 60 Contract research organizations market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 61 Strategic framework
目次
Product Code: GVR-4-68040-689-4

U.S. DNA Synthesis Market Summary

The U.S. DNA synthesis market size was estimated at USD 1.25 billion in 2024 and is projected to reach USD 4.62 billion by 2033, expanding at a CAGR of 15.93% from 2025 to 2033. This high growth is driven by increasing demand in synthetic biology, personalized medicine, and biotechnology research. Advancements in gene editing technologies and declining costs of U.S. DNA synthesis are further accelerating market expansion. The U.S. remains a key player in global genomic innovation, supported by strong investment in R&D and a well-established biotech infrastructure.

U.S. DNA Synthesis Market Report Segmentation

This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2021 to 2033. For the purpose of this report, Grand View Research has segmented the U.S. DNA synthesis market on the basis of service type, application, and end use.

  • Service Type Outlook (Revenue, USD Million, 2021 - 2033)
  • Oligonucleotide Synthesis
    • By Type
    • Standard Oligonucleotide Synthesis
    • Custom Oligonucleotide Synthesis
    • By Length
    • Less than 50 nt
    • 51-100 nt
    • 101-150 nt
    • More than 150 nt
  • Gene Synthesis
    • By Type
    • Custom Gene Synthesis
    • Gene Library Synthesis
    • By Length
    • Less than 500 nt
    • 501-1000 nt
    • 1001-1500 nt
    • 1501-2000 nt
    • 2001-2500 nt
    • More than 2500 nt
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Research and Development
    • Oligonucleotide Synthesis
    • PCR
    • NGS
    • CRISPR
    • Cloning and Mutagenesis
    • Others
    • Gene Synthesis
    • Synthetic Biology
    • Vaccine Development
    • Genetic Engineering
    • Others
  • Diagnostics
  • Therapeutics
    • RNAi Therapies
    • Antisense Oligonucleotide-based Therapies
    • Others
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Biopharmaceutical and Diagnostics Companies
  • Academic and Research Institutes
  • Contract Research Organizations

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Service Type
    • 1.2.2. Application
    • 1.2.3. End Use
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Insights Landscape

Chapter 3. U.S. DNA Synthesis Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook.
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
    • 3.2.2. Market restraint analysis
  • 3.3. U.S. DNA synthesis Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
    • 3.3.2. PESTEL Analysis

Chapter 4. U.S. DNA Synthesis Market: Service Type Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. U.S. DNA Synthesis Market Service Type Movement Analysis
  • 4.3. U.S. DNA Synthesis Market Size & Trend Analysis, by Service Type, 2021 to 2033 (USD Million)
  • 4.4. Oligonucleotide synthesis
    • 4.4.1. Oligonucleotides synthesis market estimates and forecasts 2021 to 2033 (USD Million)
    • 4.4.2. By Type
      • 4.4.2.1. Standard oligonucleotides synthesis
        • 4.4.2.1.1. Standard oligonucleotides synthesis market estimates and forecasts 2021 to 2033 (USD Million)
      • 4.4.2.2. Custom oligonucleotide synthesis
        • 4.4.2.2.1. Custom oligonucleotides synthesis market estimates and forecasts 2021 to 2033 (USD Million)
    • 4.4.3. By Length
      • 4.4.3.1. Less than 50nt
        • 4.4.3.1.1. Less than 50nt market estimates and forecasts 2021 to 2033 (USD Million)
      • 4.4.3.2. 51-100nt
        • 4.4.3.2.1. 51-100nt market estimates and forecasts 2021 to 2033 (USD Million)
      • 4.4.3.3. 101-150nt
        • 4.4.3.3.1. 101-150nt synthesis market estimates and forecasts 2021 to 2033 (USD Million)
      • 4.4.3.4. More than 150nt
        • 4.4.3.4.1. More than 150nt synthesis market estimates and forecasts 2021 to 2033 (USD Million)
  • 4.5. Gene synthesis
    • 4.5.1. Gene synthesis market estimates and forecasts 2021 to 2033 (USD Million)
    • 4.5.2. By Type
      • 4.5.2.1. Custom gene synthesis
        • 4.5.2.1.1. Custom gene synthesis market estimates and forecasts 2021 to 2033 (USD Million)
      • 4.5.2.2. Gene library synthesis
        • 4.5.2.2.1. Gene library synthesis market estimates and forecasts 2021 to 2033 (USD Million)
    • 4.5.3. By Length
      • 4.5.3.1. Less than 500nt
        • 4.5.3.1.1. Less than 500nt market estimates and forecasts 2021 to 2033 (USD Million)
      • 4.5.3.2. 501-1000nt
        • 4.5.3.2.1. 501-1000nt market estimates and forecasts 2021 to 2033 (USD Million)
      • 4.5.3.3. 1001-1500nt
        • 4.5.3.3.1. 1001-1500nt synthesis market estimates and forecasts 2021 to 2033 (USD Million)
      • 4.5.3.4. 1501-2000nt
        • 4.5.3.4.1. 1501-2000nt synthesis market estimates and forecasts 2021 to 2033 (USD Million)
      • 4.5.3.5. 2001-2500nt
        • 4.5.3.5.1. 2001-2500nt synthesis market estimates and forecasts 2021 to 2033 (USD Million)
      • 4.5.3.6. More than 2500nt
        • 4.5.3.6.1. More than 2500nt synthesis market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 5. U.S. DNA Synthesis Market: Application Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. U.S. DNA Synthesis Market Application Movement Analysis
  • 5.3. U.S. DNA Synthesis Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
  • 5.4. Research & Development
    • 5.4.1. Research & development market estimates and forecasts 2021 to 2033 (USD Million)
    • 5.4.2. Oligonucleotide synthesis
      • 5.4.2.1. Oligonucleotide synthesis tumors market estimates and forecasts 2021 to 2033 (USD Million)
      • 5.4.2.2. PCR
        • 5.4.2.2.1. PCR synthesis tumors market estimates and forecasts 2021 to 2033 (USD Million)
      • 5.4.2.3. NGS
        • 5.4.2.3.1. NGS synthesis tumors market estimates and forecasts 2021 to 2033 (USD Million)
      • 5.4.2.4. CRISPR
        • 5.4.2.4.1. CRISPR synthesis tumors market estimates and forecasts 2021 to 2033 (USD Million)
      • 5.4.2.5. Cloning and mutagenesis
        • 5.4.2.5.1. Cloning and mutagenesis synthesis tumors market estimates and forecasts 2021 to 2033 (USD Million)
      • 5.4.2.6. Others
        • 5.4.2.6.1. Others synthesis tumors market estimates and forecasts 2021 to 2033 (USD Million)
    • 5.4.3. Gene synthesis
      • 5.4.3.1. Gene synthesis market estimates and forecasts 2021 to 2033 (USD Million)
      • 5.4.3.2. Synthetic biology
        • 5.4.3.2.1. Synthetic biology tumors market estimates and forecasts 2021 to 2033 (USD Million)
      • 5.4.3.3. Vaccine development
        • 5.4.3.3.1. Vaccine development synthesis tumors market estimates and forecasts 2021 to 2033 (USD Million)
      • 5.4.3.4. Genetic engineering
        • 5.4.3.4.1. Genetic engineering synthesis tumors market estimates and forecasts 2021 to 2033 (USD Million)
      • 5.4.3.5. Others
        • 5.4.3.5.1. Others synthesis tumors market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.5. Diagnostics
    • 5.5.1. Diagnostics market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.6. Therapeutics
    • 5.6.1. Therapeutics market estimates and forecasts 2021 to 2033 (USD Million)
    • 5.6.2. RNAi therapies
      • 5.6.2.1. RNAi therapies market estimates and forecasts 2021 to 2033 (USD Million)
    • 5.6.3. Antisense and oligonucleotide-based therapies
      • 5.6.3.1. Antisense and oligonucleotide-based therapies market estimates and forecasts 2021 to 2033 (USD Million)
    • 5.6.4. Others
      • 5.6.4.1. Others market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 6. U.S. DNA Synthesis Market: End Use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. U.S. DNA Synthesis Market End Use Movement Analysis
  • 6.3. U.S. DNA Synthesis Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
  • 6.4. Biopharmaceutical & Diagnostic Companies
    • 6.4.1. Biopharmaceutical & diagnostic companies market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.5. Academic & Research Institutes
    • 6.5.1. Academic & research institutes market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.6. Contract Research Organizations
    • 6.6.1. Contract Research Organizations market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Company/Competition Categorization
  • 7.2. Strategy Mapping
  • 7.3. Company Market Position Analysis, 2024
  • 7.4. Company Profiles/Listing
    • 7.4.1. Thermo Fisher Scientific Inc.
      • 7.4.1.1. Company overview
      • 7.4.1.2. Financial performance
      • 7.4.1.3. Service benchmarking
      • 7.4.1.4. Strategic initiatives
    • 7.4.2. Twist Bioscience
      • 7.4.2.1. Company overview
      • 7.4.2.2. Financial performance
      • 7.4.2.3. Service benchmarking
      • 7.4.2.4. Strategic initiatives
    • 7.4.3. BIONEER CORPORATION
      • 7.4.3.1. Company overview
      • 7.4.3.2. Financial performance
      • 7.4.3.3. Service benchmarking
      • 7.4.3.4. Strategic initiatives
    • 7.4.4. Eton Bioscience, Inc
      • 7.4.4.1. Company overview
      • 7.4.4.2. Financial performance
      • 7.4.4.3. Service benchmarking
      • 7.4.4.4. Strategic initiatives
    • 7.4.5. LGC Biosearch Technologies
      • 7.4.5.1. Company overview
      • 7.4.5.2. Financial performance
      • 7.4.5.3. Service benchmarking
      • 7.4.5.4. Strategic initiatives
    • 7.4.6. IBA Lifesciences GmbH
      • 7.4.6.1. Company overview
      • 7.4.6.2. Financial performance
      • 7.4.6.3. Service benchmarking
      • 7.4.6.4. Strategic initiatives
    • 7.4.7. Eurofins Scientific
      • 7.4.7.1. Company overview
      • 7.4.7.2. Financial performance
      • 7.4.7.3. Service benchmarking
      • 7.4.7.4. Strategic initiatives
    • 7.4.8. Integrated DNA Technologies, Inc.
      • 7.4.8.1. Company overview
      • 7.4.8.2. Financial performance
      • 7.4.8.3. Service benchmarking
      • 7.4.8.4. Strategic initiatives
    • 7.4.9. Quintara Biosciences
      • 7.4.9.1. Company overview
      • 7.4.9.2. Financial performance
      • 7.4.9.3. Service benchmarking
      • 7.4.9.4. Strategic initiatives
    • 7.4.10. GenScript
      • 7.4.10.1. Company overview
      • 7.4.10.2. Financial performance
      • 7.4.10.3. Service benchmarking
      • 7.4.10.4. Strategic initiatives